Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Fulcrum Therapeutics, Inc. (FULC) vs Inhibikase Therapeutics, Inc. (IKT)

Fulcrum Therapeutics, Inc. and Inhibikase Therapeutics, Inc. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and Inhibikase Therapeutics, Inc. are of similar size ($293.0M and $288.8M). Fulcrum Therapeutics, Inc. grew revenue faster over the last twelve months: 1,939.8% against 110.9%. Across the 11 metrics below, Fulcrum Therapeutics, Inc. leads on 7 and Inhibikase Therapeutics, Inc. on 4.

Valuation

Metric FULC IKT Biotechnology median
P/E n/m n/m 7.88
P/S 3.46 1,380.49 11.47
P/B 0.92 2.35 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.35 n/m 0.74
EV/Sales (0.41) 770.06 10.73
Earnings yield (32.35%) (20.87%) (28.84%)
Free cash flow yield (23.03%) (11.85%) (23.03%)

Profitability

Metric FULC IKT Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (32.38%) (51.96%) (57.72%)
Return on assets (30.75%) (48.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FULC IKT Biotechnology median
Revenue growth (TTM) 1,939.80% 110.93% 5.64%
EPS growth (last fiscal year) (637.50%) 57.76% —
Revenue growth, 5-year CAGR — (42.21%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FULC IKT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.35 15.82 4.73
Net debt to EBITDA 4.23 3.44 0.96

Dividend

Metric FULC IKT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FULC IKT Biotechnology median
Market cap 288.79m 293.03m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack